Cell Captive Insurance: The Honest Pros and Cons

The structure, in one paragraph

A cell captive is a ring-fenced underwriting cell inside a licensed insurer. The insurer provides the licence, the regulatory infrastructure and the reinsurance access; your premiums fund your own cell; and the underwriting result of that cell — good or bad — belongs to the cell owner. We maintain a full explanation on our cell-captive services page. This article is the shorter, harder question: should you actually want one?

The case for

You keep your own underwriting surplus. A disciplined business with a clean claims record generates underwriting profit every year. In a conventional policy, that margin belongs to the insurer’s shareholders. In a cell, it accrues to you. This is the entire economic point of the structure.

The float works for you. Premiums and reserves held in the cell earn investment income while they wait — a second income line on top of the underwriting result.

Cover built for your risk, not the market’s average. Wordings can be designed around how your business actually operates — valuable in niches the conventional market serves badly.

Insulation from the market cycle. When the market hardens and everyone’s premiums jump 20%, a cell owner’s pricing is driven by their own book, not the pool’s losses.

Months, not years. A cell stands up in months. A standalone insurance licence takes years of prudential build-out and capital most businesses will never justify.

The case against

A bad year is your bad year. This is the clause people skim. In a conventional policy, a catastrophic claims year is the insurer’s problem. In a cell, it lands on your capital. If you are not genuinely prepared to carry downside, you want insurance, not a captive.

Capital is committed, not spent — but committed. A cell requires solvency capital held inside the structure. It is your money, working — but it is not available to your business in the meantime.

The promoter charges for the licence you are renting. Cell fees, asset-management charges, reinsurance costs — the licensed insurer is a landlord, and rent is payable in good years and bad.

It demands discipline you must actually have. The economics only work if the claims record that justified the cell continues. That means risk management as an operating habit, not a brochure claim — for years.

It is not a tax structure. If anyone sells you a cell captive on deductibility, walk away. The Western Cape High Court’s Meiring judgment in June 2026 dismantled exactly that pitch — we wrote a full analysis here. A genuine cell is taxed unremarkably. Its case rests on economics, and if the economics don’t stand on their own, the answer is no.

The honest threshold

Below roughly R1 million in annual premiums, the fixed costs of the structure eat the benefit — a well-negotiated conventional programme wins. Above it, with a claims record consistently better than the market prices you for, the question becomes genuinely worth asking. Note the second condition: a large premium with an average claims record is not a cell-captive candidate. It is an insurer’s favourite customer.

Our position

We examine cell feasibility as a standard part of auditing any large programme, and we recommend the structure in the minority of cases where the numbers support it. When they don’t, we say so in writing — because a structure that doesn’t fit is a fee in search of a justification. If your premium spend has crossed the threshold and nobody has ever run the analysis, the audit is free, and the feasibility view comes with it.